跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 18,446 条关于
“Daiichi Sankyo Co. Ltd.”
全部
18,446
临床试验
4,328
药物
1,816
机构
4,378
资讯
7,924
2年前
Tenosynovial Giant Cell Tumors Treatment Market to See Significant Growth by 2034
去年
Global Stroke Clinical Trials Landscape Analysis Reveals Key Market Trends for 2025
去年
Syros' Tamibarotene Fails Phase III Trial in MDS Patients
去年
Comprehensive HER2+ Breast Cancer Clinical Trials Report 2025 Reveals Global Research Landscape
去年
AstraZeneca to Invest $3.5 Billion in US Operations Amid Cancer Drug Sales Surge
去年
Novel Bacterial Consortium AUN Achieves Tumor Eradication Without Immune System Dependence
2年前
Merck and Daiichi Sankyo Form $22 Billion Alliance for Three Novel Antibody-Drug Conjugates
去年
AstraZeneca and Daiichi Sankyo Seek Accelerated Approval for Datopotamab Deruxtecan in EGFR-Mutated NSCLC
去年
AstraZeneca and Daiichi Sankyo Seek FDA Approval for Datopotamab Deruxtecan in EGFR-Mutated NSCLC
去年
Mixed Results for Cancer and Neurological Drugs, Regulatory Scrutiny Intensifies for PBMs
第 1 页,共 793 页
上一页
下一页